A Comparative Study of PD-L1 Protein Expression Using the Ventana SP263 Diagnostic Assay and PD-L1 mRNA Expression Using RNAscope in Formalin Fixed Paraffin Embedded Samples of Non-Small Cell Lung Cancer (NSCLC), Head and Neck Squamous Cell Carcinoma (HNSCC) and Urothelial Carcinoma (UC)

被引:0
|
作者
Duncan, D. [1 ]
Scott, M. [1 ]
Scorer, P. [1 ]
Walker, J. [2 ]
Barker, C. [1 ]
机构
[1] Precis Med & Genom, Precis Med Labs, Cambridge, England
[2] Precis Med & Genom, Oncol Compan Diagnost Unit, Cambridge, England
关键词
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
P35
引用
收藏
页码:S22 / S22
页数:1
相关论文
共 50 条
  • [31] A Machine Learning Based Algorithm for Automatic Scoring of PD-L1 SP263 in Non-Small-Cell Lung Carcinoma (NSCLC)
    Miri, Mohammad Saleh
    Nguyen, Kien
    Earley, Keith
    Selck, Stefanie
    Patil, Suhas
    Zuiderveld, Karel
    Manriquez, Guadalupe
    Hayden, Dorothy
    Vennapusa, Bharathi
    Guetter, Christoph
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 1479 - 1480
  • [32] Assessing PD-L1 Expression in Head and Neck Squamous Cell Carcinoma: Trials and Tribulations
    Ruben Bill
    William C. Faquin
    Sara I. Pai
    Head and Neck Pathology, 2023, 17 : 969 - 975
  • [33] A Machine Learning Based Algorithm for Automatic Scoring of PD-L1 SP263 in Non-Small-Cell Lung Carcinoma (NSCLC)
    Miri, Mohammad Saleh
    Kien Nguyen
    Earley, Keith
    Selck, Stefanie
    Patil, Suhas
    Zuiderveld, Karel
    Manriquez, Guadalupe
    Hayden, Dorothy
    Vennapusa, Bharathi
    Guetter, Christoph
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 1479 - 1480
  • [34] Prognostic significance of PD-L1 expression in patients with head and neck squamous cell carcinoma
    Peng, C.
    Gu, X.
    Gao, X. S.
    Li, X.
    Qin, S.
    Ma, M.
    Cui, M.
    Xie, M.
    Bai, Y.
    RADIOTHERAPY AND ONCOLOGY, 2017, 123 : S267 - S268
  • [35] Assessing PD-L1 Expression in Head and Neck Squamous Cell Carcinoma: Trials and Tribulations
    Bill, Ruben
    Faquin, William C.
    Pai, Sara I.
    HEAD & NECK PATHOLOGY, 2023, 17 (04) : 969 - 975
  • [36] Prognostic Significance of PD-L1 Expression in Patients with Head and Neck Squamous Cell Carcinoma
    Peng, C.
    Gao, X. S.
    Gu, X.
    Ma, M.
    Li, X.
    Qi, X.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E365 - E365
  • [37] Investigation of PD-L1 expression and tislelizumab efficacy in gastroesophageal adenocarcinoma using a novel tumor and immune cell score with VENTANA PD-L1 (SP263) assay and Combined Positive Score (CPS)
    Chao, Y.
    Yang, S.
    Zhang, Y.
    Shen, Z.
    Wu, X.
    Wang, J.
    Quiroz, M.
    Nielsen, A.
    Liu, C.
    Desai, J.
    ANNALS OF ONCOLOGY, 2020, 31 : S300 - S300
  • [38] Interobserver concordance of PD-L1 clones SP263 and E1L3N in non-small cell lung carcinoma (NSCLC): two centre study
    Bozkurtlar, E.
    Karaman, D.
    Batur, S.
    VIRCHOWS ARCHIV, 2021, 479 (SUPPL 1) : S51 - S52
  • [39] PD-L1 expression testing in non-small cell lung cancer
    Teixido, Cristina
    Vilarino, Noelia
    Reyes, Roxana
    Reguart, Noemi
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2018, 10
  • [40] PD-L1 Expression in Patients with Non-small Cell Lung Cancer
    Masago, Katsuhiro
    Fujita, Shiro
    Hata, Akito
    Okuda, Chiyuki
    Kaji, Reiko
    Katakami, Nobuyuki
    Hirata, Yukio
    ANTICANCER RESEARCH, 2017, 37 (05) : 2269 - 2274